An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target

BackgroundEndometriosis is a chronic, heterogeneous disease with limited non-hormonal treatment options. Drug repurposing provides an accelerated route to identify safe, tolerable, and potentially effective therapies for endometriosis. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) was inves...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Kate Gunther, Dongli Liu, Gill Stannard, Melissa Holmes, Christine Loo, Belinda Guo, Nikola Bowden, Jason Abbott, Caroline E. Ford
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2025-12-01
סדרה:	Frontiers in Pharmacology
נושאים:	endometriosis drug repurposing Ror1 organoid reimegepant
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1716062/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!